Page last updated: 2024-08-21

malondialdehyde and pitavastatin

malondialdehyde has been researched along with pitavastatin in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ban, N; Endo, K; Kawana, H; Miyashita, Y; Nagayama, D; Ohira, M; Oyama, T; Saiki, A; Shirai, K; Yamaguchi, T	1
Hayashi, S; Taguchi, A	1
Imai, N; Kobara, M; Nakata, T; Ohigashi, M; Toba, H	1

Trials

2 trial(s) available for malondialdehyde and pitavastatin

Article	Year
Effects of pitavastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, on cardio-ankle vascular index in type 2 diabetic patients. Journal of atherosclerosis and thrombosis, 2009, Volume: 16, Issue:5 Topics: 8-Hydroxy-2'-Deoxyguanosine; Aged; Ankle; Deoxyguanosine; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Male; Malondialdehyde; Middle Aged; Pulsatile Flow; Quinolines	2009
[Study of MDA-LDL by pioglitazone and pitavastatin in patients with type 2 diabetes]. Nihon rinsho. Japanese journal of clinical medicine, 2011, Volume: 69, Issue:1 Topics: Aged; Arteriosclerosis; Biomarkers; Cholesterol, LDL; Coronary Artery Disease; Diabetes Mellitus, Type 2; Disease Progression; Dyslipidemias; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Pioglitazone; Quinolines; Risk Factors; Thiazolidinediones	2011

Article

Year

Effects of pitavastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, on cardio-ankle vascular index in type 2 diabetic patients.

Journal of atherosclerosis and thrombosis, 2009, Volume: 16, Issue:5

Topics: 8-Hydroxy-2'-Deoxyguanosine; Aged; Ankle; Deoxyguanosine; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Male; Malondialdehyde; Middle Aged; Pulsatile Flow; Quinolines

2009

[Study of MDA-LDL by pioglitazone and pitavastatin in patients with type 2 diabetes].

Nihon rinsho. Japanese journal of clinical medicine, 2011, Volume: 69, Issue:1

Topics: Aged; Arteriosclerosis; Biomarkers; Cholesterol, LDL; Coronary Artery Disease; Diabetes Mellitus, Type 2; Disease Progression; Dyslipidemias; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Pioglitazone; Quinolines; Risk Factors; Thiazolidinediones

2011

Other Studies

1 other study(ies) available for malondialdehyde and pitavastatin

Article	Year
Pitavastatin Exhibits Protective Effects on Podocytes Accompanied by BMP-7 Up-Regulation and Rho Suppression. Pharmacology, 2016, Volume: 97, Issue:5-6 Topics: Animals; Bone Morphogenetic Protein 7; Chemokine CCL2; Creatinine; Diabetes Mellitus, Experimental; Gene Expression; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intracellular Signaling Peptides and Proteins; Kidney; Male; Malondialdehyde; Membrane Proteins; Nitrates; Nitrites; Protective Agents; Proteinuria; Quinolines; Rats, Wistar; rho-Associated Kinases; Transforming Growth Factor beta; Up-Regulation	2016

Article

Year

Pitavastatin Exhibits Protective Effects on Podocytes Accompanied by BMP-7 Up-Regulation and Rho Suppression.

Pharmacology, 2016, Volume: 97, Issue:5-6

Topics: Animals; Bone Morphogenetic Protein 7; Chemokine CCL2; Creatinine; Diabetes Mellitus, Experimental; Gene Expression; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intracellular Signaling Peptides and Proteins; Kidney; Male; Malondialdehyde; Membrane Proteins; Nitrates; Nitrites; Protective Agents; Proteinuria; Quinolines; Rats, Wistar; rho-Associated Kinases; Transforming Growth Factor beta; Up-Regulation

2016